COMPARISON OF HISTOLOGICAL TYPES AND SOME PATHOLOGIC FEATURES OF COLORECTAL AND RECTAL CARCINOMA

Thi Tuyen Nguyen1,, Thi Yen Dang1, Thi Ha Thanh Nguyen1, Thi Nhu Quynh Nguyen1
1 University of Medical Technology and Pharmacy at Da Nang

Main Article Content

Abstract

Background: Colorectal cancer is one of the most common cancers in the world. During pathological staging, patients are divided into different prognostic groups based on three factors: the level of invasion of the primary tumor, the number of metastatic lymph nodes and the presence of distant metastatic sites. Objectives: To determine the rate of histological types and compares with some pathologic features of colorectal and rectal carcinoma. Materials and methods: Cross-sectional study describing 156 cases operated on and histopathologically diagnosed as colorectal carcinoma, at Da Nang Oncology Hospital from January 2018 to the end of August 2020. Re-read the specimens, classify the histological type, invasion, lymph node metastasis, and distant metastasis according to the WHO 2010 classification. Results: Adenocarcinoma NOS has the highest rate of 80.1%; T3 invasion accounts for the highest rate of 60.3%. The lymph node metastasis rate is 47.5%; The rate of distant metastasis is 9.0%. Mucinous adenocarcinoma and signet ring cell carcinoma have a higher invasion rate of T3 and T4 than the other types. The mucinous, ring cell, micropapillary and cribriform comedo-types have a high rate of positive lymph nodes. This difference is statistically significant with p < 0.05. In the singlesite metastasis group M1a, micropapillary carcinoma has a higher rate of single-site metastasis than the conventional adenoma type. However, in the M1c peritoneal metastasis group, the ring type predominates at a rate of 33.3% compared to conventional adenocarcinoma with p < 0.05. Conclusion: Conventional breast cancer accounts for the highest rate; T3 invasion has the highest rate. The lymph node metastasis rate is 47.5%; The rate of distant metastasis is 9.0%. There is a relationship between histopathological type and the degree of invasion and lymph node metastasis with p<0.05.

Article Details

References

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal AJCacjfc. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 2018. 68(6), 394-424, doi: 10.3322/caac.21492
2. Trần Thắng. Nghiên cứu áp dụng hóa trị bổ trợ phác đồ FUFA trong điều trị ung thư biểu mô tuyến đại tràng. Luận án tiến sĩ y học: Trường Đại học Y Hà Nội. 2012.
3. Đặng Trần Tiến. Nghiên cứu hình thái học của ung thư đại trực tràng. Tạp chí Y học TP Hồ Chí Minh. 2007. 11(3), 86-8.
4. Chu Văn Đức. Nghiên cứu bộc lộ một số dấu ấn hóa mô miễn dịch và mối liên quan với đặc điểm mô bệnh học trong ưng thư biểu mô đại trực tràng. Luận Án tiến sĩ: Đại học Y Hà Nội. 2015.
5. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumors of the digestive system: World Health Organization. 2010.
6. Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. 2012.118(3), 628-38, doi: 10.1002/cncr.26310.
7. Priolli D, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CRJTic. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. 2009. 13, 113-21, doi: 10.1007/s10151-009-0467-5.
8. Marzouk O, Schofield JJC. Review of histopathological and molecular prognostic features in colorectal cancer. 2011. 3(2), 2767-810, doi: 10.3390/cancers3022767.
9. Balta AZ, Özdemir Y, Sücüllü İ, Derici ST, Bağcı M, Demirel D, et al. Can horizontal diameter of colorectal tumor help predict prognosis? 2014. 30(3), 115, doi: 10.5152/UCD.2014.2701.
10. Nguyễn Quang Thái. Nghiên cứu kết quả phẫu thuật cắt trước thấp điều trị ung thư trực tràng tại bệnh viện K. Tạp chí Ung thư học Việt Nam. 2019. 1, 327-33.
11. Nguyễn Thị Phương Thảo. Đánh giá kết quả phác đồ Bevacizumab phối hợp Xelox trong điều trị ung thư đại trực tràng giai đoạn IV. Tạp chí Ung thư học Việt Nam, . 2019. 1, 339-43.
12. Nagtegaal ID, Hugen NJCCCR. The increasing relevance of tumor histology in determining oncological outcomes in colorectal cancer. 2015. 11, 259-66, doi: 10.1007/s11888-015-0280-7.
13. Sung CO, Seo JW, Kim K-M, Do I-G, Kim SW, Park C-KJMP. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma. 2008. 21(12), 1533-41, doi: 10.1038/modpathol.2008.170.
14. Nguyễn Thanh Tâm. Nghiên cứu tổn thương hạch trong ung thư biểu mô đại trực tràng được phẫu thuật triệt căn. 2010.
15. Razenberg LG, van Gestel YR, Lemmens VE, de Wilt JH, Creemers G-J, de Hingh IHJCCC. The prognostic relevance of histological subtype in patients with peritoneal metastases from colorectal cancer: a nationwide population-based study. 2015. 14(4), e13-e9, doi: 10.1016/j.clcc.2015.05.011.